THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 83 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,979 | -99.9% | 176,426 | +15.9% | 0.00% | +50.0% |
| Q3 2022 | $1,543,000 | +250.7% | 152,177 | +795.0% | 0.00% | – |
| Q4 2019 | $440,000 | -55.0% | 17,003 | -57.8% | 0.00% | -100.0% |
| Q2 2018 | $977,000 | 0.0% | 40,300 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $977,000 | +448.9% | 40,300 | +270.4% | 0.00% | – |
| Q4 2015 | $178,000 | -94.8% | 10,880 | -95.9% | 0.00% | -100.0% |
| Q2 2015 | $3,435,000 | +1535.7% | 263,816 | +1772.9% | 0.01% | +700.0% |
| Q4 2014 | $210,000 | – | 14,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |